Search

everythinglearnresearchcommunity

for

Search:↓

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Accurate diagnosis of rare scalp cancer requires combining clinical and radiological information.

An elderly woman's upper lip lump, thought to be a mucocele, was actually a rare type of lymphoma usually found on legs, treated successfully with chemotherapy and radiation.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

A benign tumor developed at a girl's BCG vaccination site, not previously linked to the vaccine.

A rare ovarian tumor caused a postmenopausal woman to develop male-like features, which improved after surgery.

Chemotherapy causes hair loss, nausea, fatigue, and blood issues, but counseling can help manage these effects.

A rare skin cancer on a man's elbow was successfully treated with surgery, showing no recurrence after one year.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

HPV infection is linked to better survival in advanced anal cancer, higher radiation doses improve survival, especially in HPV-negative patients, and prostaglandin E₂ pretreatment can protect mouse hair follicles from radiation damage.

Tacalcitol ointment effectively improves bilateral nevus comedonicus.

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

Surgeons should know about pilomatricoma for accurate diagnosis, even though it's rare.

Trichilemmoma, BCC, and SCC tumors have different stem cell marker expressions.

Dermoscopy can non-invasively detect eruptive vellus hair cysts on the labia majora.

A 79-year-old man was diagnosed with a rare skin condition called nevus comedonicus on his eyelids.

COVID-19 affects patients on chemotherapy for gynecological cancer negatively.

Different skin conditions show distinct types of vessel inflammation, a new quality of life index for vulval disease is reliable, a certain intrauterine system might be linked to chronic vaginal yeast infections, and oral minoxidil reduces hair loss in women.

Pre-surgical embolization and a two-stage resection improve outcomes for rare sacral tumors.

Scalp basal cell carcinoma may be more aggressive and harder to treat than other types, requiring special attention and further research.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Seborrheic keratosis is a common, harmless skin growth that can look like cancer, so it may need a biopsy.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

Complete removal of scalp tumors is crucial, but malignant cases may recur or metastasize, requiring a multidisciplinary approach and close follow-up.

Early detection and complete surgical removal are crucial for better outcomes in treating pilomatrix carcinoma.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Ion channels play a key role in ovarian cancer growth and treatment resistance.